{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T23:39:50Z","timestamp":1768779590361,"version":"3.49.0"},"reference-count":6,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T00:00:00Z","timestamp":1366848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Addict"],"published-print":{"date-parts":[[2013,5]]},"abstract":"<jats:sec><jats:title>Background and Objectives<\/jats:title><jats:p>Research has indicated that the buprenorphine\u2010mono product yields maternal outcomes similar to methadone and a less severe neonatal abstinence syndrome. However, maternal and neonatal outcomes following buprenorphine\u2009+\u2009naloxone exposure during pregnancy have not been documented.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Retrospective chart review identified 10 opioid\u2010dependent pregnant women treated with the buprenorphine\u2009+\u2009naloxone film product between January, 2010\u2010June, 2011. Seven maternal outcome measures \u2013 weight gain, fetal presentation at delivery, Cesarean delivery, analgesia during delivery, urine drug screening results at delivery, number of days of maternal hospital stay, and began breastfeeding following delivery\u2014and eleven neonatal outcome measures\u2014gestational age at delivery, 1\u2010 and 5\u2010minute Apgar scores, head circumference, length, and weight at birth, treated for neonatal abstinence syndrome (NAS), total amount of morphine sulfate needed to treat NAS, length of hospital stay for NAS treatment, and length of hospital stay\u2014were extracted from medical records.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Maternal findings were unremarkable, and comparable with what might be found following treatment with the buprenorphine\u2010mono product. Neonates were full\u2010term with normal birth parameters. Four neonates were treated for NAS, and number of days treated for NAS and number of hospital days were in line with values reported for the buprenorphine\u2010mono product.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Findings suggest no obvious significant adverse maternal or neonatal outcomes related to the use of buprenorphine\u2009+\u2009naloxone for the treatment of opioid dependence during pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Scientific Significance<\/jats:title><jats:p>These initial findings underscore the need for future research to systematically examine the relative safety and effectiveness of buprenorphine\u2009+\u2009naloxone for mother, fetus, and child. (Am J Addict 2013; 22:252\u2013254)<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1521-0391.2012.12005.x","type":"journal-article","created":{"date-parts":[[2013,4,25]],"date-time":"2013-04-25T15:55:23Z","timestamp":1366905323000},"page":"252-254","source":"Crossref","is-referenced-by-count":67,"title":["Buprenorphine\u2009+\u2009Naloxone in the Treatment of Opioid Dependence during Pregnancy\u2014Initial Patient Care and Outcome Data"],"prefix":"10.1111","volume":"22","author":[{"given":"Kimber","family":"Debelak","sequence":"first","affiliation":[{"name":"Recovery Pathways Bay City, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William R.","family":"Morrone","sequence":"additional","affiliation":[{"name":"Synergy Medical Education Alliance, Central Michigan University College of Medicine Saginaw, Michigan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin E.","family":"O'Grady","sequence":"additional","affiliation":[{"name":"Department of Psychology University of Maryland, College Park College Park, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendr\u00e9e E.","family":"Jones","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park North Carolina"},{"name":"Departments of Psychiatry and Behavioral Sciences and Obstetrics and Gynecology Johns Hopkins University School of Medicine Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,4,25]]},"reference":[{"key":"e_1_2_5_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1005359"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1586\/ern.09.26"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0866-05.2005"},{"key":"e_1_2_5_5_1","volume-title":"Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Addiction. Treatment Improvement Protocol (TIP) Series 40. DHHS Publication No. (SMA) 04\u20103939","author":"Center for Substance Abuse Treatment","year":"2004"},{"key":"e_1_2_5_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2012.04035.x"},{"key":"e_1_2_5_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.11.013"}],"container-title":["The American Journal on Addictions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1521-0391.2012.12005.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1521-0391.2012.12005.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T08:43:51Z","timestamp":1698655431000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1521-0391.2012.12005.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,25]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["10.1111\/j.1521-0391.2012.12005.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1521-0391.2012.12005.x","archive":["Portico"],"relation":{},"ISSN":["1055-0496","1521-0391"],"issn-type":[{"value":"1055-0496","type":"print"},{"value":"1521-0391","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,25]]}}}